BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31465840)

  • 61. Hedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma.
    Zhou XT; Ding J; Li HY; Zuo JL; Ge SY; Jia HL; Wu J
    J Cell Mol Med; 2020 Apr; 24(7):4298-4311. PubMed ID: 32108992
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The GANT61, a GLI inhibitor, induces caspase-independent apoptosis of SK-N-LO cells.
    Matsumoto T; Tabata K; Suzuki T
    Biol Pharm Bull; 2014; 37(4):633-41. PubMed ID: 24694609
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model.
    Garcia N; Ulin M; Ali M; Al-Hendy A; Carvalho KC; Yang Q
    Reprod Sci; 2022 Mar; 29(3):781-790. PubMed ID: 34642915
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 synergizes with chloroquine to induce apoptosis in embryonal rhabdomyosarcoma.
    Hugle M; Fulda S
    Cancer Lett; 2015 Apr; 360(1):1-9. PubMed ID: 25637161
    [TBL] [Abstract][Full Text] [Related]  

  • 65. GLI1-targeting drugs induce replication stress and homologous recombination deficiency and synergize with PARP-targeted therapies in triple negative breast cancer cells.
    Mani C; Tripathi K; Omy TR; Reedy M; Manne U; Palle K
    Biochim Biophys Acta Mol Basis Dis; 2022 Feb; 1868(2):166300. PubMed ID: 34748904
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells.
    Desch P; Asslaber D; Kern D; Schnidar H; Mangelberger D; Alinger B; Stoecher M; Hofbauer SW; Neureiter D; Tinhofer I; Aberger F; Hartmann TN; Greil R
    Oncogene; 2010 Sep; 29(35):4885-95. PubMed ID: 20603613
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Repression of Mcl-1 and disruption of the Mcl-1/Bak interaction in myeloma cells couple ER stress to mitochondrial apoptosis.
    Gomez-Bougie P; Halliez M; Moreau P; Pellat-Deceunynck C; Amiot M
    Cancer Lett; 2016 Dec; 383(2):204-211. PubMed ID: 27697610
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice.
    Moshai EF; Wémeau-Stervinou L; Cigna N; Brayer S; Sommé JM; Crestani B; Mailleux AA
    Am J Respir Cell Mol Biol; 2014 Jul; 51(1):11-25. PubMed ID: 24450438
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeting the Hedgehog pathway in combination with X‑ray or carbon ion radiation decreases migration of MCF‑7 breast cancer cells.
    Konings K; Belmans N; Vermeesen R; Baselet B; Lamers G; Janssen A; Isebaert S; Baatout S; Haustermans K; Moreels M
    Int J Oncol; 2019 Dec; 55(6):1339-1348. PubMed ID: 31638201
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cafestol overcomes ABT-737 resistance in Mcl-1-overexpressed renal carcinoma Caki cells through downregulation of Mcl-1 expression and upregulation of Bim expression.
    Woo SM; Min KJ; Seo BR; Nam JO; Choi KS; Yoo YH; Kwon TK
    Cell Death Dis; 2014 Nov; 5(11):e1514. PubMed ID: 25375379
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of the CyclinD1 promoter in response to sonic hedgehog signaling pathway transduction is mediated by Gli1.
    Lin Z; Sheng H; You C; Cai M; Zhang Y; Yu LS; Yu X; Lin J; Zhang N
    Exp Ther Med; 2017 Jan; 13(1):307-314. PubMed ID: 28123507
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation.
    Juric V; Hudson L; Fay J; Richards CE; Jahns H; Verreault M; Bielle F; Idbaih A; Lamfers MLM; Hopkins AM; Rehm M; Murphy BM
    Cell Death Dis; 2021 Aug; 12(8):763. PubMed ID: 34344865
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Effect of Hedgehog Signaling Pathway Abnormality on Chemothe-rapeutic Resistance of Multiple Myeloma].
    Hu JS; Huang X; Huang YD; Lu YY; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):465-470. PubMed ID: 28446294
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibition of Bcl-2/Bcl-xL and c-MET causes synthetic lethality in model systems of glioblastoma.
    Zhang Y; Ishida CT; Shu C; Kleiner G; Sanchez-Quintero MJ; Bianchetti E; Quinzii CM; Westhoff MA; Karpel-Massler G; Siegelin MD
    Sci Rep; 2018 May; 8(1):7373. PubMed ID: 29743557
    [TBL] [Abstract][Full Text] [Related]  

  • 75. GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma.
    Borah A; Pillai SC; Rochani AK; Palaninathan V; Nakajima Y; Maekawa T; Kumar DS
    Nanotechnology; 2020 May; 31(18):185102. PubMed ID: 31952056
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enhanced apoptotic effects by downregulating Mcl-1: evidence for the improvement of photodynamic therapy with Celecoxib.
    Song J; Chen Q; Xing D
    Exp Cell Res; 2013 Jun; 319(10):1491-504. PubMed ID: 23524145
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).
    Leverson JD; Zhang H; Chen J; Tahir SK; Phillips DC; Xue J; Nimmer P; Jin S; Smith M; Xiao Y; Kovar P; Tanaka A; Bruncko M; Sheppard GS; Wang L; Gierke S; Kategaya L; Anderson DJ; Wong C; Eastham-Anderson J; Ludlam MJ; Sampath D; Fairbrother WJ; Wertz I; Rosenberg SH; Tse C; Elmore SW; Souers AJ
    Cell Death Dis; 2015 Jan; 6(1):e1590. PubMed ID: 25590800
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Co-targeting of BET proteins and HDACs as a novel approach to trigger apoptosis in rhabdomyosarcoma cells.
    Enßle JC; Boedicker C; Wanior M; Vogler M; Knapp S; Fulda S
    Cancer Lett; 2018 Aug; 428():160-172. PubMed ID: 29709701
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hedgehog signaling pathway is active in GBM with GLI1 mRNA expression showing a single continuous distribution rather than discrete high/low clusters.
    Chandra V; Das T; Gulati P; Biswas NK; Rote S; Chatterjee U; Ghosh SN; Deb S; Saha SK; Chowdhury AK; Ghosh S; Rudin CM; Mukherjee A; Basu A; Dhara S
    PLoS One; 2015; 10(3):e0116390. PubMed ID: 25775002
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.
    Wellbrock J; Latuske E; Köhler J; Wagner K; Stamm H; Vettorazzi E; Vohwinkel G; Klokow M; Uibeleisen R; Ehm P; Riecken K; Loges S; Thol F; Schubert C; Amling M; Jücker M; Bokemeyer C; Heuser M; Krauter J; Fiedler W
    Clin Cancer Res; 2015 May; 21(10):2388-98. PubMed ID: 25745035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.